Strategies used to enable the vaccine for Covid-19 in Brazil and the pandemic paradigma

Ana Beatriz Nascimento Ayres,Xisto Lucas Travassos,Renelson Ribeiro Sampaio
DOI: https://doi.org/10.53660/clm-1046-23c58
2023-03-31
Concilium
Abstract:The pandemic caused by the SARS-CoV-2 virus, a new strain identified in humans and the etiologic agent of Covid-19 represents a health threat to humanity. There are currently seven members of this viral family, known to infect humans, with the potential to cause severe respiratory diseases. In order to meet this demand, the development of an effective vaccine has been a challenge, and the reduction of time for its development has been the most important, since this process consists of several phases, being a long and resource-intensive one. This work aims to study the challenge to make vaccination viable for the population in Brazil, breaking the paradigms of time between research and the final product already distributed among the populations, is of fundamental importance, as well as to identify which were the main actors, articulations, obstacles and investments undertaken so that, in less than a year after the decree of the state of global emergency, the vaccines were approved for clinical trials.
What problem does this paper attempt to address?